SAN DIEGO, Jan. 9 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will be presenting at the JPMorgan H&Q 20th Annual Healthcare Conference being held in San Francisco on Thursday, January 10, 2002 at 12:00PM Pacific Time (3:00PM Eastern Time). The presentation will be simultaneously Webcast and can be viewed through a link provided via the JPMorgan H&Q website at http://php4.eventsdigital.com/events/jpmhq/healthcare2002

Gary Lyons, President and CEO of Neurocrine will discuss the Company's insomnia program as well as highlighting the Company's pipeline. If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. The presentation will be archived for 30 days.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .

    Contact: Claudia Jones at 858-658-7600.

                    MAKE YOUR OPINION COUNT -  Click Here
               http://tbutton.prnewswire.com/prn/11690X68169959

SOURCE Neurocrine Biosciences, Inc.
Web site: http: //www.neurocrine.com
CONTACT: Claudia Jones or Paul Hawran of Neurocrine Biosciences, Inc., +1-858-658-7600